Hydrazine hydrate (1:1) → 4-Trifluoromethylphenyl-[1,2]diazepino[4,5,6-cd]indol-6-one
Reaction equation
C1([C:7]2[C:13]3=[CH:14][NH:15][C:16]4[CH:17]=[CH:18][CH:19]=[C:11]([C:12]=43)[C:10](=[O:20])[NH:9][N:8]=2)C=CC=CC=1.N1C2C=CC=C(C(OC)=O)C=2C=C1.[F:34][C:35]([F:46])([F:45])[C:36]1[CH:44]=[CH:43][C:39](C(Cl)=O)=[CH:38][CH:37]=1.[Cl-].[Al+3].[Cl-].[Cl-].O.NN>ClC(Cl)C.CO.Cl>[F:34][C:35]([F:46])([F:45])[C:36]1[CH:44]=[CH:43][C:39]([C:14]2[C:13]3=[CH:7][N:8]=[N:9][C:10](=[O:20])[C:11]4[C:12]3=[C:16]([CH:17]=[CH:18][CH:19]=4)[N:15]=2)=[CH:38][CH:37]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Procedure
In a manner similar to that described for Compound 28, a solution of methyl indole-4-carboxylate (250 mg, 1.43 mmol) in dichloroethane (3 mL) was treated with p-trifluoromethylbenzoyl chloride (445 mg, 2.14 mmol) and aluminum chloride (572 mg). The intermediate ketone (95 mg, 0.27 mmol) in MeOH (3 mL) and conc. HCl (0.05 mL) was treated, as described, with hydrazine hydrate (0.1 mL). The reaction was quenched at 0° C. with w M NaOAc and the aqueous layer was adjusted to pH=8 with 1 M NaOH. The product was isolated by extraction with CH2Cl2, and recrystallized (CH2Cl2/hexanes) to give 1,5-dihydro-3-(4-trifluoromethylphenyl-[1,2]diazepino[4,5,6-cd]indol-6-one, 30 mg (34%) as a yellow solid: 1H NMR (300 MHz, d6-DMSO) δ 7.24 (app br t, 1H), 7.29 (d, J=2.8 Hz, 2H), 7.60 (m, 2H), 7.82 (m, 4H), 10.57 (s, 1H), 12.01 (s, 1H). HRMS (FAB, Mna+) Calcd for C11H10N3Ona: 352.0674. Found: 352.0668.
Workup
- customThe reaction was quenched at 0° C. with w M NaOAc
- customThe product was isolated by extraction with CH2Cl2
- customrecrystallized (CH2Cl2/hexanes)
Sources & evidence
- ORD record
- ord-a70c0399768a4671821172362cf6c4f3
- Source dataset
- uspto-grants-2008_09
- Patent number
- US07429578B2
Reaction notes
Loading…